2018
DOI: 10.14356/kona.2018020
|View full text |Cite
|
Sign up to set email alerts
|

Powder Particles and Technologies for Medicine Delivery to the Respiratory System: Challenges and Opportunities

Abstract: The paper discusses essential engineering challenges related to the application of powder medicines for pulmonary delivery as inhaled aerosol. Starting from a physically based description of the complexity of aerosol dynamics inside the respiratory system, the paper discusses several technical factors responsible for efficient drug delivery to the lungs: (i) interparticle interactions-which can be tuned by selection and control of powder manufacturing methods, (ii) inhaler design-as a determinant of flow dynam… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 18 publications
(2 citation statements)
references
References 92 publications
0
2
0
Order By: Relevance
“…The most important point is that dry powders can be aerosolized easily with a low air-flow rate and low pressure that are in the normal range for inhalation. As inhalable dry powders often display coagulating properties caused by cohesiveness and adhesiveness ( 27 , 28 ), the development of formulations producing fine and dispersed powders is necessary ( 29 ).…”
Section: Discussionmentioning
confidence: 99%
“…The most important point is that dry powders can be aerosolized easily with a low air-flow rate and low pressure that are in the normal range for inhalation. As inhalable dry powders often display coagulating properties caused by cohesiveness and adhesiveness ( 27 , 28 ), the development of formulations producing fine and dispersed powders is necessary ( 29 ).…”
Section: Discussionmentioning
confidence: 99%
“…Based on the size distribution of aerosol particles, two essential factors were evaluated: the volumetric median diameter (VMD = D V 50) and the percentage of particle fraction smaller than 5 µm (fine particle fraction, FPF). Both of the parameters are the essential quality indicators of aerosol that is produced by the inhalation drug delivery system [ 42 , 43 ]. In addition, the percentage of particles smaller than 10 µm (inhalable particles) and value of span were determined.…”
Section: Methodsmentioning
confidence: 99%